GASTROENTERIL® Oral suspension
Gastroenteril® oral suspension, is indicated for the treatment of diarrhea associated with Giardias, in dogs and cats. It is also indicated in enteric and systemic infections caused by obligate anaerobic bacteria sensitive to Metronidazole.
Product Description
SPECIES
Dogs and cats.
DOSAGE FORM
Oral suspension.
THERAPEUTIC ACTION
Antimicrobial – Antiprotozoal.
COMPOSITION
Each 100 ml of the product contains:
Metronidazole………………..2.5 g
Excipients q.s.p……………100 mL
INDICATIONS
Gastroenteril® oral suspension, is indicated for the treatment of diarrhea associated with Giardias, in dogs and cats. It is also indicated in enteric and systemic infections caused by obligate anaerobic bacteria sensitive to Metronidazole.
ROUTE OD ADMINISTRATION AND DOSAGE
Oral route.
Giardiasis and anaerobic infections:
- Active ingredient dose: 25 mg of Metronidazole / Kg, every 12 hours for 5-7 days *.
- Product dose: 1 mL / Kg of weight, twice a day for 5 to 7 days *.
* In the case of systemic anaerobic infections, therapy can be prolonged for 6 weeks.
DRUG INTERACTIONS
- Metronidazole may prolong prothrombin time in patients taking Warfarin or other coumarin anticoagulants.
- Phenobarbital or Phenytoin may increase the metabolism of Metronidazole and increase the likelihood of dose related side effects.
CONTRAINDICATIONS
- Do not administer to patients with hypersensitivity to Metronidazole or nitroimidazole derivatives.
- Do not use during pregnancy, lactation or in breeding animals.
SPECIAL PRECAUTIONS FOR THE OPERATOR
- Wash hands after use.
- Do not handle by people hypersensitive to Metronidazole.
- In case of contact with skin, eyes or mucosa, immediately wash with plenty of water.
- Do not handle by pregnant women.
- In case of accidental ingestion, immediately go to a medical center and show the product label.
- Do not eat, smoke or drink during its administration.
WARNINGS
Special warnings and precautions for use:
- Gastroenteril® oral suspension should be used with caution in animals with liver dysfunction. In case of significant liver impairment, use 25-50% of the usual dose.
- Keep out of the reach of children.
ADVERSE EFFECTS
Vomiting, hepatotoxicity, neutropenia. In prolonged treatments, neurological signs, which completely subside once the use of the product has been discontinued.
OBSERVATIONS
Shake vigorously before use.
Special precautions for the disposal of unused product or waste material:
Empty containers can be discarded as household waste without any special precautions. Do not dispose of the containers with the rest of the product on the ground or water courses. For expired or unused products, contact the manufacturing laboratory.
CONSERVATION
- Store at a temperature between 2 and 30 ° C, protected from light.
- Once opened, use the product within 3 months. Discard the unused product after that period of time.
CONDITION OF SALE
To be supply only on veterinary prescription.
PRESENTATION
120 ml bottle.
PREPARED BY
Drag Pharma Laboratory.
RECORDS
Chile: Reg. SAG N° 2036
Costa Rica: Reg. N° MAG CL4-42-18-5785
Uruguay: Reg. MGAP N° 2016A00378
Bolivia: Reg. SENASAG PUV-F-N° 006142/14
Perú: Registro SENASA F.91.02.I.0005
COUNTRIES WHERE IT IS MARKETED
Uruguay:
Importador:
VIVAFIL S.A.
RIO NEGRO 1107 Montevideo – Uruguay,
TEL 29001112
grupotecnovet@gmail.com
Director Técnico: DMTV Diego Cuadrado.
Bolivia:
Importado y distribuido por:
AGROGUARANI SRL
TEL: +(591)314-1401
Santa Cruz de la Sierra-Bolivia
Perú:
Importado y Distribuido por Representaciones Durand SAC.
Av. Manuel Olguín N° 501 Oficina N° 604 Santiago de Surco Lima.